UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010476
Receipt number R000012246
Scientific Title A randomized, double blind, placebo-controlled trial of Oxibarrier.
Date of disclosure of the study information 2013/07/01
Last modified on 2016/04/13 10:10:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized, double blind, placebo-controlled trial of Oxibarrier.

Acronym

A randomized, double blind, placebo-controlled trial of Oxibarrier.

Scientific Title

A randomized, double blind, placebo-controlled trial of Oxibarrier.

Scientific Title:Acronym

A randomized, double blind, placebo-controlled trial of Oxibarrier.

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the efficacy of taking Oxibarrier on sleep.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

(1) Sleep log
(2) Athens Insomnia Scale

Key secondary outcomes

(3) Actigraph
(4) Pittsburgh sleep quality index
(5) SF-8 acute


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Taking Oxibarrier for two weeks, and then taking Placebo for two weeks after wash-out for two weeks.

Interventions/Control_2

Taking Placebo for two weeks, and then taking Oxibarrier for two weeks after wash-out for two weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

60 years-old >

Gender

Male

Key inclusion criteria

(1) subjective complaint of difficulties initiating (sleep latency >30 min) or maintaining sleep (time awake after sleep onset >30 min) for a month.
(2) general good health without evidence of clinically significant disease as determined by medical history, physical examination, and urine drug screens.
(3) The score of Pittsburgh sleep quality index: 5-8

Key exclusion criteria

(1) disease that could affect the action of the study
(2) current or past history of serious, severe, or unstable physical (eg, congestive heart failure, chronic obstructive pulmonary disease, diabetes, thyroid disease) or psychiatric illness (eg, major depression, generalized anxiety disorder)
(3) evidence of another sleep disorder (eg, sleep apnea, restless legs syndrome, periodic limb movements), irregular sleep patterns, or occupations involving evening or night shift work
(4) allergies or suspected intolerance to the study medications or any antihistamines
(5) current use of substances or medications known to affect sleep, including prescription psychotropics, sedatives, hypnotics, nicotine-replacement therapies, over-the-counter
sleep aids, or herbal products
(6) current or recent (within 1 year) alcohol or drug abuse

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuichi Inoue

Organization

Tokyo Medical University

Division name

Department of Somnology

Zip code


Address

6-7-1 Nishishinjuku, Shinjuku, Tokyo

TEL

03-3351-6141

Email

yuinoue@tokyo-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoko Komada

Organization

Tokyo Medical University

Division name

Department of Somnology

Zip code


Address

6-7-1 Nishishinjuku, Shinjuku, Tokyo

TEL

03-3351-6141

Homepage URL

http://www.tokyo-med.ac.jp/sleep/

Email

ykoma@tokyo-med.ac.jp


Sponsor or person

Institute

Department of Somnology, Tokyo Medical University

Institute

Department

Personal name



Funding Source

Organization

FUJIFILM Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2013 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 04 Month 12 Day

Last modified on

2016 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012246


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name